StockBaat

Actis, Sequoia plan stake sale in Paras for $700 mn: report: Private equity companies Actis Capital and Sequoia Capital plan to sell a controlling stake in India's Paras Pharmaceuticals for as much as $700 million, Bloomberg reported on Tuesday. http://bit.ly/czIict